Associations of the CXCL12–CXCR4 pathway in supporting metastasis and disease severity have also been demonstrated using HCC cell lines, showing increased MMP2 and MMP9 secretion (84) and decreased 3-year-survival rates in patients (85). The gene discussed is CXCR4; the disease is hepatocellular carcinoma.